Potential kidney damage associated with the use of remdesivir for COVID-19: analysis of a pharmacovigilance database
Abstract: The U.S. Food and Drug Administration (FDA) has stated that the prescription of remdesivir should be cautious for patients with estimated glomerular filtration rate (eGFR) < 30 and some studies reported risk of adverse renal events. The available information on the renal safety profile for...
Na minha lista:
| Principais autores: | , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Escola Nacional de Saúde Pública Sergio Arouca, Fundação Oswaldo Cruz
2021-11-01
|
| Serier: | Cadernos de Saúde Pública |
| Fag: | |
| Online adgang: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0102-311X2021001005024&tlng=en |
| Tags: |
Ingen Tags, Vær først til at tagge denne postø!
|
